Literature DB >> 23960204

Abnormal retinoid and TrkB signaling in the prefrontal cortex in mood disorders.

Xin-Rui Qi1, Jun Zhao2, Ji Liu2, Hui Fang2, Dick F Swaab3, Jiang-Ning Zhou2.   

Abstract

The prefrontal cortex shows structural and functional alterations in mood disorders. Retinoid signaling, brain-derived neurotrophic factor (BDNF), and its receptor TrkB are reported to be involved in depression. Here, we found that mRNA levels of key elements of retinoid signaling were significantly reduced in the postmortem dorsolateral prefrontal cortex/anterior cingulate cortex (ACC) from elderly depressed patients who did not die from suicide. Decreased mRNA levels of BDNF and TrkB isoforms were also found. Similar alterations were observed in rats subjected to chronic unpredictable mild stress. Along with neurons immunopositive for both retinoic acid receptor-α (RARα) and TrkB, a positive correlation between mRNA levels of the 2 receptors was found in the ACC of control subjects but not of depressed patients. In vitro studies showed that RARα was able to bind to and transactivate the TrkB promoter via a putative RA response element within the TrkB promoter. In conclusion, the retinoid and BDNF-TrkB signaling in the prefrontal cortex are compromised in mood disorders, and the transcriptional upregulation of TrkB by RARα provide a possible mechanism for their interaction. The retinoid signaling pathway that may activate TrkB expression will be an alternative novel target for BDNF-based antidepressant treatment.
© The Author 2013. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  anterior cingulate cortex; brain-derived neurotrophic factor; dorsolateral prefrontal cortex; mood disorder; retinoic acid receptor-α

Mesh:

Substances:

Year:  2013        PMID: 23960204     DOI: 10.1093/cercor/bht203

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  20 in total

1.  Optic nerve injury upregulates retinoic acid signaling in the adult frog visual system.

Authors:  Mildred V Duprey-Díaz; Jonathan M Blagburn; Rosa E Blanco
Journal:  J Chem Neuroanat       Date:  2016-05-27       Impact factor: 3.052

2.  Transcriptomic Analysis Reveals Sex-Dependent Expression Patterns in the Basolateral Amygdala of Dominant and Subordinate Animals After Acute Social Conflict.

Authors:  Katharine E McCann; David M Sinkiewicz; Anna M Rosenhauer; Linda Q Beach; Kim L Huhman
Journal:  Mol Neurobiol       Date:  2018-09-08       Impact factor: 5.590

3.  Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor.

Authors:  Satoshi Deyama; Eunyoung Bang; Taro Kato; Xiao-Yuan Li; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2018-12-27       Impact factor: 13.382

Review 4.  A Slice of the Suicidal Brain: What Have Postmortem Molecular Studies Taught Us?

Authors:  Daniel Almeida; Gustavo Turecki
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

Review 5.  Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date.

Authors:  Vladimir Lerner; Peter J A McCaffery; Michael S Ritsner
Journal:  CNS Drugs       Date:  2016-04       Impact factor: 5.749

6.  Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine.

Authors:  Satoshi Deyama; Eunyoung Bang; Eric S Wohleb; Xiao-Yuan Li; Taro Kato; Danielle M Gerhard; Sophie Dutheil; Jason M Dwyer; Seth R Taylor; Marina R Picciotto; Ronald S Duman
Journal:  Am J Psychiatry       Date:  2019-01-04       Impact factor: 18.112

Review 7.  Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.

Authors:  Satoshi Deyama; Ronald S Duman
Journal:  Pharmacol Biochem Behav       Date:  2019-12-09       Impact factor: 3.533

8.  Peripheral nerve injury and gabapentin, but not their combination, impair attentional behavior via direct effects on noradrenergic signaling in the brain.

Authors:  Takashi Suto; James C Eisenach; Ken-Ichiro Hayashida
Journal:  Pain       Date:  2014-05-15       Impact factor: 6.961

Review 9.  The best-laid plans go oft awry: synaptogenic growth factor signaling in neuropsychiatric disease.

Authors:  Aislinn J Williams; Hisashi Umemori
Journal:  Front Synaptic Neurosci       Date:  2014-03-18

10.  Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders.

Authors:  M T Ray; C Shannon Weickert; M J Webster
Journal:  Transl Psychiatry       Date:  2014-05-06       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.